SciFed Drug Delivery Research Journal

To Evaluate the Role of Nano-Particles in Drug Delivery and Design


Received on: July 24, 2017

Accepted on: October 24, 2017

Published on: October 30, 2017

Haque SS

*Corresponding author: Department of Biochemistry, Indira Gandhi Institute of Medical Sciences



        Nanotechnology defined nanotechnology as "technology conducted at the nano scale level, which is about 1 to 100 nano meters". Nano-technological application is greatly important in the field of drug delivery because of its high specificity towards the target site, so it is able to reduce toxic side effects of drugs to normal cells. Reduce plasma fluctuation of drugs, high solubility, efficiency, reduces cost of products and enhancement of patience comfort are reasons that nanotechnology is used for drug delivery. Nano particles (NP) have emerged as important platforms for efficient diagnostics and therapeutics by merging the characteristic properties they possess at the nano-metric scale with the feasible immobilization of specific ligands on the surface. Therefore, they have become ideal candidates for molecularly sensitive detection, highly efficient contrast agents for molecular imaging, as well as carriers for targeted drug and gene delivery, and therapeutical reagents for targeted photo thermal therapy [1]. The nano particle (NP) plays a vital role and it can conjugate with various drugs by different methods to deliver drugs to the target site. Abraxane was the first nano particle drug formulation to receive US-FDA approval in 2005, which is Manometer-Albumin-Bound (NAB) paclitaxel for head and neck cancer, metastatic breast cancer, non-small cell lung cancer and anal cancer.
        Brain cancer is one of the most difficult malignancies to detect and treat mainly because of the difficulty in getting imaging and therapeutic agents past the blood-brain barrier and into the brain. Anti-cancer drugs such as loperamide and doxorubicin bound to nano-materials have been shown to cross the intact blood-brain barrier and released at therapeutic concentrations in the brain. Recently Scientists have developed NPs of the size of macro molecules such as DNA and proteins that are smaller than diameter of a double stranded DNA (2nm). The smallest cellular form in the world is a bacterium named mycoplasma. Which has the size of 200nm but in comparison the largest NP is only 100nm in size. Quantum dots, chitosan, Poly lactic/glycolic acid (PLGA) and PLGA-based nano particles have also been used for in vitro RNAi delivery. New Drug delivery system (DDS) has the ability to deliver drugs to specific target cells in various areas of the body without degradation in the gastrointestinal track. It includes delivery and targeting of pharmaceutical, therapeutical and diagnostic agents by the help of NPs to the cells such as cancer cells. The ultimate goal of NP drug delivery is to improve the proper treatment diagnostics and prevention of disease [2,3]. DDS is defined by national institute of health in USA as, "Formulation of a device that enables the introduction of therapeutic substances in to the body and improves efficiency and safety by the control the rate, time and place of release of drug in the body."
     Nanotechnology can be developed in future to treat all type of diseases in human at the same time by producing multi-functional nano-particles. The introduction of bio-compatible materials and devices that are engineered on the nanometer scale that interact with biological molecules and cells and provide specified diagnostic, therapeutic, and imaging functions will utterly change the way in which health care is provided in the future.


  1. Bamrungsap S, Huang YF, Carmen EM, et al. Nanoparticles for molecular diagnostics and therapy.
  2. Ochekpe NA, Olorunfemi PO, Ngwuluka NC (2009) Nanotechnology and Drug Delivery Part 1: Background and Applications. Tropical Journal of Pharmaceutical Research 8: 265-274.
  3. Bamrungsap S, Zhao Z, Chen T, et al. (2012) Nanotechnology in Therapeutics A Focus on Nanoparticles as a Drug Delivery System. Nano medicine 7: 1253-1271.